|Day Low/High||153.51 / 160.16|
|52 Wk Low/High||135.29 / 189.46|
We held back on any big portfolio moves as the quarter ended with bank stress test results and merger news.
The most recent short interest data has been released for the 06/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Cramer shares his views on Oracle's re-rating and also discusses the constant battle between growth and value.
Tech rotation, oil and Fed rate hike keep markets on even (flat) keel. Several portfolio positions get beefed up.
Tech rotation, oil and Fed rate hike keep markets on even (make that flat) keel. Several portfolio positions get beefed up.
Chief accounting officer Greg Covino will serve as Biogen's interim principal financial officer while the firm searches for a new finance chief.
Jim Cramer says the OLED revolution is finally here, and investors should be on the lookout for opportunities.
Go inside Jim Cramer's Apple call.
Acceleron Pharma, Clovis Oncology and Coherus BioSciences premarket trading on Tuesday.
Here's why Cramer is holding onto GE's stock.
Jim Cramer is bullish on Charles Schwab, Essent Group, Cara Therapeutics, and MGM Growth Properties.
Mark Butler, chairman, president and CEO of Ollie's Bargain Outlet tells Jim Cramer everybody loves a great deal.
Jim Cramer says there's one company that thrives when the mercury rises, and that's Pool Corp.
After a busy Thursday, markets look forward to economic data and the Fed meeting next week. In the portfolio, we dropped a tech stock and added a healthcare name.
Kevin Conroy, chairman, president and CEO at Exact Sciences, tells Jim Cramer about his company's non-invasive test for colon cancer.
Jim Cramer says investors must determine for themselves if they can stomach the volatility created by the risks some companies take.
Jim Cramer is bullish on Advanced Micro Devices, Micron Technology, and Charles River Labs.
Andrew Liveris, chairman and CEO of Dow Chemical, talks with Jim Cramer about climate change and DuPont deal.
Jim Cramer has the game plan for next week, including earnings from Thor Industries and HD Supply.
Stocks start to recover from recent setbacks. Portfolio moves include a tech-stock downgrade.
Markets rebound amid headlines about oil, Trump and other news. Portfolio moves include an airline downgrade.
The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 383,884 share increase in total short interest for Snap-On, Inc. , to 3,831,425, an increase of 11.14% since 04/28/2017.
If AutoZone's earnings are good, that could mean good things for Action Alerts PLUS holding Snap-On.
Buy shares of Snap-On if AutoZone reports a good quarter, according to TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.